3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Breast Cancer -

Specialists improve breast cancer care

Breast CancerSep 10, 05

Elderly women with Breast cancer whose surgeons refer them to cancer specialists are twice as likely to be prescribed tamoxifen, a treatment recommended for preventing recurrence of the disease, a new study shows.

“Older women should be given the opportunity to have these conversations with medical oncologists,” said Dr. Rebecca A. Silliman of the Boston University School of Public Health, the study’s lead author.

While tamoxifen has long been recommended for older women with estrogen-receptor-positive Breast cancers, except those with extremely low-risk tumors, older women are less likely than younger patients to receive definitive care, Silliman and her colleagues note in the medical journal Cancer.

Silliman’s team conducted the current study to see if older women who met with a medical oncologist were more likely to be prescribed tamoxifen therapy when appropriate.

The study included 559 patients 65 years of age or older with early-stage Breast cancer treated by 191 surgeons. The women were interviewed by telephone 3, 6 and 15 months after surgery.

Seventy-nine percent of the participants had been referred to medical oncologists, somewhat lower than the 88 percent seen among younger patients in other research, the investigators report. Sicker patients were roughly half as likely to be referred as healthier patients.

There is “growing evidence,” the researchers note, that variations in cancer care seen with age may lead to worse outcomes for older people. “Our findings suggest that more consistent referral of older women to medical oncologists may enhance the quality of discussions and decisions concerning treatment options,” they conclude.

“The main implication is that treatment decision-making in cancer, whether it’s Breast cancer or any other kind of cancer, is complex and obviously emotionally charged,” Silliman added.

“I think offering older women the same kind of opportunity for treatment decision-making conversations is really important, because many of these women have a substantial future life expectancy,” she concluded.

SOURCE: Cancer, September 1, 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Fat grafting technique improves results of breast augmentation
  UW research shows sensor technology may help improve accuracy of clinical breast exams
  Generic Breast Cancer Drugs Boost Adherence
  New models of drug-resistant breast cancer point to better treatments
  Breast tomosynthesis increases cancer detection and reduces recall rates
  2 views are better than 1 in 3-D breast screening
  Study reveals genomic similarities between breast cancer and ovarian cancers
  Moderate exercise tied to lower breast cancer risk
  Risk for some cancers rises with U.S. obesity rate
  New genomic test spares patients chemotherapy with no adverse effect on survival
  Breast Cancer In Black Women Is A Different Disease
  Combination of Everolimus and Exemestane Improves Progression-Free Survival for Women with Metastatic Breast Cancer

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site